Skip to content
← Back to this collection

PUBLICATIONS · 8329700

Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
Blood
Publication date
1993 Jul 15
First author
Hehlmann R

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships

    Authors and identifiers

    1. name
      Hehlmann R
      type
      Author
    2. name
      Heimpel H
      type
      Author
    3. name
      Hasford J
      type
      Author
    4. name
      Kolb HJ
      type
      Author
    5. name
      Pralle H
      type
      Author
    6. name
      Hossfeld DK
      type
      Author
    7. name
      Queisser W
      type
      Author
    8. name
      Löffler H
      type
      Author
    9. name
      Heinze B
      type
      Author
    10. name
      Georgii A
      type
      Author
    Complete bibliographic record and source provenance
    authors
    1. name
      Hehlmann R
      type
      Author
    2. name
      Heimpel H
      type
      Author
    3. name
      Hasford J
      type
      Author
    4. name
      Kolb HJ
      type
      Author
    5. name
      Pralle H
      type
      Author
    6. name
      Hossfeld DK
      type
      Author
    7. name
      Queisser W
      type
      Author
    8. name
      Löffler H
      type
      Author
    9. name
      Heinze B
      type
      Author
    10. name
      Georgii A
      type
      Author
    bibliography ids
    1. nci-bib-ec7eaabf224642ff2b73d5e9
    book metadata
    content sha256
    669c788859d17e50e000a3ee41dfb300567345042074c18a95b2b17ad120785d
    document type
    citation
    dois
      electronic publication date
      display
      Source null
      precision
      missing
      year
      Source null
      evidence scope
      bibliographic_metadata_only
      id
      pubmed:8329700
      immutable id
      pubmed:8329700@669c788859d17e50e000a3ee41dfb300567345042074c18a95b2b17ad120785d
      journal
      abbreviation
      Blood
      issn electronic
      Source null
      issn print
      0006-4971
      issue
      2
      name
      Blood
      nlm unique id
      7603509
      pages
      398-407
      volume
      82
      languages
      1. eng
      notices
      absence is not clearance
      true
      has correction metadata
      false
      has expression of concern metadata
      false
      has retraction in link
      false
      pubmed marks article retracted
      false
      pubmed marks retraction notice
      false
      relationships
        outcomes validated
        false
        pmid
        8329700
        provenance
        batch id
        83ec39f94a925b232876
        provider
        NCBI PubMed ESummary
        record sha256
        6d0085dee153fb036e8a46603328b9e499104ebe8fdd0ca477bf1c90e8aac4b0
        response sha256
        9cea37bf3451de6aa8c54c490de635080a496054249095b8c254be0e69164eca
        retrieved at
        2026-09-09T23:45:20.996485+00:00
        publication date
        display
        1993 Jul 15
        precision
        day
        year
        1993
        publication types
        1. Clinical Trial
        2. Comparative Study
        3. Journal Article
        4. Multicenter Study
        5. Randomized Controlled Trial
        6. Research Support, Non-U.S. Gov't
        record status
        PubMed - indexed for MEDLINE
        schema version
        1.0
        source url
        https://pubmed.ncbi.nlm.nih.gov/8329700/
        title
        Randomized comparison of busulfan and hydroxyurea in chronic myelogenous leukemia: prolongation of survival by hydroxyurea. The German CML Study Group.

        Preserved source evidence · Not medical advice